Peters PN - Search Results

1

Oncolytic adenovirus MEM-288 encoding membrane-stable CD40L and IFNβ induces an anti-tumor immune response in high grade serous ovarian cancer.

Peters PN, Whitaker RS, Lim F, Russell S, Bloom EA, Pollara J, Strickland KC, Cantwell MJ, Beg A, Berchuck A, Antonia S, Previs RA. Peters PN, et al. Neoplasia. 2024 Nov;57:101056. doi: 10.1016/j.neo.2024.101056. Epub 2024 Sep 13. Neoplasia. 2024. PMID: 39276533 Free PMC article.

2

Development and Characterization of a Luciferase Labeled, Syngeneic Murine Model of Ovarian Cancer.

Russell S, Lim F, Peters PN, Wardell SE, Whitaker R, Chang CY, Previs RA, McDonnell DP. Russell S, et al. Among authors: peters pn. Cancers (Basel). 2022 Aug 30;14(17):4219. doi: 10.3390/cancers14174219. Cancers (Basel). 2022. PMID: 36077756 Free PMC article.

3

Association of Genomic Instability Score, Tumor Mutational Burden, and Tumor-Infiltrating Lymphocytes as Biomarkers in Uterine Serous Carcinoma.

Bloom EA, Peters PN, Whitaker R, Russell S, Albright B, Cummings S, Timms KM, Slavin T, Probst B, Strickland KC, Previs RA. Bloom EA, et al. Among authors: peters pn. Cancers (Basel). 2023 Jan 15;15(2):528. doi: 10.3390/cancers15020528. Cancers (Basel). 2023. PMID: 36672477 Free PMC article.

4

PET-detected asymptomatic recurrence is associated with improved survival in recurrent cervical cancer.

Peters PN, Pierson WE, Chen LM, Westphalen AC, Chapman JS, Hsu IC. Peters PN, et al. Abdom Radiol (NY). 2021 Jan;46(1):341-350. doi: 10.1007/s00261-020-02633-0. Epub 2020 Jul 8. Abdom Radiol (NY). 2021. PMID: 32638077

5

Cost-effectiveness of management strategies for patients with recurrent ovarian cancer and inoperable malignant bowel obstruction.

Peters PN, Moyett JM, Davidson BA, Cantrell S, Bliss SE, Havrilesky LJ. Peters PN, et al. Gynecol Oncol. 2022 Dec;167(3):523-531. doi: 10.1016/j.ygyno.2022.10.013. Epub 2022 Nov 4. Gynecol Oncol. 2022. PMID: 36344293

6

Primary treatment of advanced ovarian cancer: how does the 'real world' practice?

Craig AD, Garcia E, Peters PN, Chen LM, Chapman JS. Craig AD, et al. Among authors: peters pn. Future Oncol. 2021 Dec;17(34):4687-4696. doi: 10.2217/fon-2021-0086. Epub 2021 Aug 26. Future Oncol. 2021. PMID: 34435878

7

Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal Cavity.

Peters PN, Schryver EM, Lengyel E, Kenny H. Peters PN, et al. J Vis Exp. 2015 Dec 31;(106):e53541. doi: 10.3791/53541. J Vis Exp. 2015. PMID: 26780294 Free PMC article.

8

Novel Therapies in Gynecologic Cancer.

Bejar FG, Oaknin A, Williamson C, Mayadev J, Peters PN, Secord AA, Wield AM, Coffman LG. Bejar FG, et al. Among authors: peters pn. Am Soc Clin Oncol Educ Book. 2022 Apr;42:1-17. doi: 10.1200/EDBK_351294. Am Soc Clin Oncol Educ Book. 2022. PMID: 35594502 Free article.

9

Guidelines for goals of care discussions in patients with gynecologic cancer.

Peters PN, Havrilesky LJ, Davidson BA. Peters PN, et al. Gynecol Oncol. 2023 Jul;174:247-252. doi: 10.1016/j.ygyno.2023.05.016. Epub 2023 May 25. Gynecol Oncol. 2023. PMID: 37243995 Review.

10

An integrated molecular profile of endometrioid ovarian cancer.

Pierson WE, Peters PN, Chang MT, Chen LM, Quigley DA, Ashworth A, Chapman JS. Pierson WE, et al. Among authors: peters pn. Gynecol Oncol. 2020 Apr;157(1):55-61. doi: 10.1016/j.ygyno.2020.02.011. Epub 2020 Mar 3. Gynecol Oncol. 2020. PMID: 32139151 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters